Product logins

Find logins to all Clarivate products below.


: Cortellis

Here you will find relevant articles and insight into all Clarivate related products and news.

Understanding a rare disease through the lens of real world and prevalence data Understanding a rare disease through the lens of real world and prevalence data
Blog February 28, 2023
Understanding a rare disease through the lens of real world and prevalence data
Cortellis Epidemiology Pharma
Understanding local CMC requirements in low-resource countries Understanding local CMC requirements in low-resource countries
Blog December 11, 2020
Understanding local CMC requirements in low-resource countries
Cortellis
Blog August 31, 2020
Identifying and evaluating new products to rise above the competition
Cortellis
Blog August 23, 2020
Making data driven decisions with reliable intelligence
Cortellis
Blog August 12, 2020
Securing the best price for an out-licensed asset
Cortellis
Confidently complying with global regulatory guidelines Confidently complying with global regulatory guidelines
Blog August 10, 2020
Confidently complying with global regulatory guidelines
Cortellis
Blog August 1, 2020
Understanding when a drug can become generic
Cortellis
Blog July 16, 2020
Conducting pathway analyses to accelerate discovery research
Cortellis

Cortellis

Blog February 28, 2017
The Case for Continued Surveillance of Human Prion Diseases
Blog February 16, 2017
Cortellis Deals Landscape Q4 2016
Blog January 24, 2017
Deals up, dollars down – diverging trends are unsustainable
Blog November 23, 2016
India has been hit by a Chikungunya outbreak. What is this disease?
Blog November 22, 2016
Recap: Notable Life Sciences Merger & Acquisitions in Q3 2016
Blog November 21, 2016
Pharma Experts Cautiously Optimistic about Industry’s Regulatory Challenges
Blog November 14, 2016
Chikungunya, a Neglected Tropical Disease, has Re-emerged as a Global Health Risk
Blog November 2, 2016
Need to Make Changes to Your Clinical Trial? It'll Cost Money and Time
Blog February 3, 2014
Alzheimer’s disease: One year later